日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Amplification of the therapeutic potential of AMPA receptor potentiators from the nootropic era to today

从益智药时代到今天,AMPA受体增强剂的治疗潜力不断增强

Radin, Daniel P; Lippa, Arnold; Rana, Sabhya; Fuller, David D; Smith, Jodi L; Cerne, Rok; Witkin, Jeffrey M

AMPA receptors play an important role in the biological consequences of spinal cord injury: Implications for AMPA receptor modulators for therapeutic benefit

AMPA受体在脊髓损伤的生物学后果中发挥重要作用:AMPA受体调节剂的治疗意义

Witkin, Jeffrey M; Radin, Daniel P; Rana, Sabhya; Fuller, David D; Fusco, Anna F; Demers, Julie C; Pradeep Thakre, Prajwal; Smith, Jodi L; Lippa, Arnold; Cerne, Rok

(R)-(-)-Ketamine: The Promise of a Novel Treatment for Psychiatric and Neurological Disorders

(R)-(-)-氯胺酮:治疗精神和神经疾病的新希望

Shafique, Hana; Demers, Julie C; Biesiada, Julia; Golani, Lalit K; Cerne, Rok; Smith, Jodi L; Szostak, Marta; Witkin, Jeffrey M

New Imidazodiazepine Analogue, 5-(8-Bromo-6-(pyridin-2-yl)-4H-benzo[f]imidazo[1,5-a][1,4]diazepin-3-yl)oxazole, Provides a Simplified Synthetic Scheme, High Oral Plasma and Brain Exposures, and Produces Antiseizure Efficacy in Mice, and Antiepileptogenic Activity in Neural Networks in Brain Slices from a Patient with Mesial Temporal Lobe Epilepsy

一种新型咪唑并二氮杂卓类似物,5-(8-溴-6-(吡啶-2-基)-4H-苯并[f]咪唑并[1,5-a][1,4]二氮杂卓-3-基)噁唑,具有合成路线简化、口服血浆和脑暴露量高等优点,在小鼠中表现出抗癫痫疗效,并在内侧颞叶癫痫患者脑片的神经网络中表现出抗癫痫发生活性。

Sharmin, Dishary; Divović, Branka; Ping, Xingjie; Cerne, Rok; Smith, Jodi L; Rezvanian, Sepideh; Mondal, Prithu; Meyer, Michelle Jean; Kiley, Molly E; Arnold, Leggy A; Mian, Md Yeunus; Pandey, Kamal P; Jin, Xiaoming; Mitrović, Jelena R; Djorović, Djordje; Lippa, Arnold; Cook, James M; Golani, Lalit K; Scholze, Petra; Savić, Miroslav M; Witkin, Jeffrey M

KRM-II-81 suppresses epileptifom activity across the neural network of cortical tissue from a patient with pharmacoresistant epilepsy

KRM-II-81抑制了药物难治性癫痫患者皮质组织神经网络中的癫痫样活动。

Smith, Jodi L; Wertz, Jeremy; Lippa, Arnold; Ping, Xingjie; Jin, Xiaoming; Cook, James M; Witkin, Jeffrey M; Cerne, Rok

GABAkines - Advances in the discovery, development, and commercialization of positive allosteric modulators of GABA(A) receptors

GABAkines——GABA(A)受体正向变构调节剂的发现、开发和商业化进展

Cerne, Rok; Lippa, Arnold; Poe, Michael M; Smith, Jodi L; Jin, Xiaoming; Ping, Xingjie; Golani, Lalit K; Cook, James M; Witkin, Jeffrey M

Metabolism, pharmacokinetics, and anticonvulsant activity of a deuterated analog of the α2/3-selective GABAkine KRM-II-81

α2/3选择性GABA能受体激动剂KRM-II-81的氘代类似物的代谢、药代动力学和抗惊厥活性

Golani, Lalit K; Divović, Branka; Sharmin, Dishary; Pandey, Kamal P; Mian, Md Yeunus; Cerne, Rok; Zahn, Nicolas M; Meyer, Michelle J; Tiruveedhula, Veera V N P B; Smith, Jodi L; Ping, Xingjie; Jin, Xiaoming; Lippa, Arnold; Schkeryantz, Jeffrey M; Arnold, Leggy A; Cook, James M; Savić, Miroslav M; Witkin, Jeffrey M

N-Substituted-3-alkoxy-derivatives of dextromethorphan are functional NMDA receptor antagonists in vivo: Evidence from an NMDA-induced seizure model in rats

右美沙芬的N-取代-3-烷氧基衍生物在体内是功能性NMDA受体拮抗剂:来自NMDA诱导的大鼠癫痫模型的证据

Witkin, Jeffrey M; Cerne, Rok; Newman, Amy H; Izenwasser, Sari; Smith, Jodi L; Tortella, Frank C

The Positive Allosteric Modulator of α2/3-Containing GABA(A) Receptors, KRM-II-81, Is Active in Pharmaco-Resistant Models of Epilepsy and Reduces Hyperexcitability after Traumatic Brain Injury

KRM-II-81是一种α2/3亚基GABA(A)受体的正向变构调节剂,在药物难治性癫痫模型中具有活性,并能降低创伤性脑损伤后的过度兴奋性。

Witkin, Jeffrey M; Li, Guanguan; Golani, Lalit K; Xiong, Wenhui; Smith, Jodi L; Ping, Xingjie; Rashid, Farjana; Jahan, Rajwana; Cerne, Rok; Cook, James M; Jin, Xiaoming

Reduction in Overt and Silent Stroke Recurrence Rate Following Cerebral Revascularization Surgery in Children with Sickle Cell Disease and Severe Cerebral Vasculopathy

镰状细胞病合并严重脑血管病患儿脑血管重建术后显性及隐性卒中复发率降低

Hall, Erin M; Leonard, Jeffrey; Smith, Jodi L; Guilliams, Kristin P; Binkley, Michael; Fallon, Robert J; Hulbert, Monica L